Phillip Fleshner, MD

Shierley Jesslyne and Emmeline Widjaja Chair in Colorectal Surgery

Director, Colorectal Surgery Research

Professor, Surgery

Phillip Fleshner, MD

8737 Beverly Blvd
Ste 101
Los AngelesCA
90048

Phone:

310-289-9224

Fax:

310-289-8995

Phillip Fleshner, MD

Shierley Jesslyne and Emmeline Widjaja Chair in Colorectal Surgery

Director, Colorectal Surgery Research

Professor, Surgery

  • Surgery-Colo-Rectal
  • Surgical Oncology

Blood in Stool

Colonoscopy

Colorectal Cancer Screening (Colon, Rectal)

Colorectal Polyps (Colon, Rectal)

Hemorrhoids

Inflammatory Bowel Disease (IBD)

Polyposis

Rectal Bleeding

Sigmoidoscopy

The main clinical and research interests of Phillip Fleshner, MD, are directed towards optimizing outcomes and techniques in the surgical management of Crohn's disease and ulcerative colitis. Fleshner has written numerous articles for peer-reviewed publications, including the Journal of the American College of Surgeons, Diseases of the Colon and Rectum, Gut, American Journal of Surgery and Annals of Surgery.

  • Medical School: Albert Einstein College of Medicine, New York, 1984
  • Fellowship: Massachusetts General Hospital, 1988
  • Residency: Mount Sinai Medical Center, 1990
  • Fellowship: Lahey Clinic, 1991
  • Northwest Society of Colon and Rectal Surgeons Award, American Society of Cataract and Refractive Surgery Annual Meeting, 2013
  • Golden Apple Teaching Award, Department of Surgery, Cedars-Sinai, 1994, 1995, 2002
  • American Society of Colon and Rectal Surgeons Traveling Fellow Award, 1994
  • Harry E. Bacon Foundation Award, 1993
  • Arthur H. Aufses Sr. Prize in Surgery Award, 1990

Click here for a list of peer-reviewed publications.

  • Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, Kambal A, Monaco CL, Zhao G, Fleshner P, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015;60(3):447-460.
  • Zaghiyan K, McGovern D, Fleshner P. Should biologic agents be stopped before surgery for inflammatory bowel disease? Expert Rev Gastroenterol Hepatol. 2015 Mar;9(3):269-272.
  • Lau C, Dubinsky M, Melmed G, Vasiliauskas E, Berel D, McGovern D, Ippoliti A, Shih D, Targan S, Fleshner P. The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease. Ann Surg. 2015;261(3):487-496.

English

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.